LIVQ_STRLV
ID LIVQ_STRLV Reviewed; 546 AA.
AC Q2MF66;
DT 06-MAR-2013, integrated into UniProtKB/Swiss-Prot.
DT 21-FEB-2006, sequence version 1.
DT 03-AUG-2022, entry version 49.
DE RecName: Full=6'''-hydroxyparomomycin C oxidase;
DE EC=1.1.3.-;
DE AltName: Full=Lividomycin biosynthesis protein Q;
GN Name=livQ;
OS Streptomyces lividus.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=282216;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, PATHWAY, AND CATALYTIC
RP ACTIVITY.
RC STRAIN=CBS 844.73;
RX PubMed=21689223; DOI=10.1111/j.1365-2672.2011.05082.x;
RA Clausnitzer D., Piepersberg W., Wehmeier U.F.;
RT "The oxidoreductases LivQ and NeoQ are responsible for the different 6'-
RT modifications in the aminoglycosides lividomycin and neomycin.";
RL J. Appl. Microbiol. 111:642-651(2011).
CC -!- FUNCTION: Glucosaminyl-6'-oxidase involved in the biosynthetic pathway
CC of lividomycin by mediating FAD-dependent dehydrogenation of 6'''-
CC hydroxyparomomycin to paromomycin. {ECO:0000269|PubMed:21689223}.
CC -!- COFACTOR:
CC Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC -!- PATHWAY: Antibiotic biosynthesis; lividomycin biosynthesis.
CC {ECO:0000269|PubMed:21689223}.
CC -!- SIMILARITY: Belongs to the GMC oxidoreductase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AJ748832; CAG38701.1; -; Genomic_DNA.
DR AlphaFoldDB; Q2MF66; -.
DR SMR; Q2MF66; -.
DR KEGG; ag:CAG38701; -.
DR BioCyc; MetaCyc:MON-17269; -.
DR BRENDA; 1.1.3.44; 13009.
DR UniPathway; UPA00968; -.
DR GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR GO; GO:0016899; F:oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor; IDA:UniProtKB.
DR GO; GO:0017000; P:antibiotic biosynthetic process; IDA:UniProtKB.
DR Gene3D; 3.50.50.60; -; 3.
DR InterPro; IPR036188; FAD/NAD-bd_sf.
DR InterPro; IPR000172; GMC_OxRdtase_N.
DR InterPro; IPR007867; GMC_OxRtase_C.
DR Pfam; PF05199; GMC_oxred_C; 1.
DR Pfam; PF00732; GMC_oxred_N; 1.
DR SUPFAM; SSF51905; SSF51905; 1.
PE 1: Evidence at protein level;
KW Antibiotic biosynthesis; FAD; Flavoprotein; Oxidoreductase.
FT CHAIN 1..546
FT /note="6'''-hydroxyparomomycin C oxidase"
FT /id="PRO_0000421738"
FT REGION 1..30
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 475
FT /note="Proton acceptor"
FT /evidence="ECO:0000250|UniProtKB:E4QP00"
SQ SEQUENCE 546 AA; 58907 MW; 249969633EF22C38 CRC64;
MERLRGPSPL ENTTARHPAP LGPAHRDGLE PGTADRVWDV CVIGSGASGA VAADRLVRQG
LDVLMVEEGF RLAPHVGLDE AESLSRQALA RDGEGNWTDE GWPWTTSNLG GGTVYYGGAS
FRYRPFDFDP GELVHTDGVD VRWPYTLADL VPYYEVLERR LGVCGGDAPG IHRGSRHSRG
PAHQPSPAAR VLRAAGESLG YRPFPTPLAI NRDPHGGRAA CARDSLCVSH LCPTGAKGDV
VAVFLAPLAA HPNFALRTGV RALRLEQDRS GEVAAVRCLD RQTGQAHRVR ARVYVVACNA
IQSAALLLRS RTPYSPDGVG NHSHLVGRGL CMKLSEYLSG TVDADPAVLA DPYTNTGPFS
TVAFLDHYLD PDCPGGFGGL IYESKRDQRH KLVHDALELR IETILADHPN LDNRVGLSTH
LDEDGMPAVV IDYTPDPRDL DRLRYMTGRC ERLLRTAGAR GIRSRSTGFA QGSSHLHGTC
RAGHDPARSV VDAWGRVHSA DNVYIVDGSF MPYPGGLNPT LTIQAHALRT SRAIASHLAA
DRAAHV